Century Therapeutics, Inc.
NASDAQ:IPSC
Overview | Financials
Company Name | Century Therapeutics, Inc. |
Symbol | IPSC |
Currency | USD |
Price | 1.26 |
Market Cap | 106,742,160 |
Dividend Yield | 0% |
52-week-range | 1.14 - 5.51 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Gregory Russotti Ph.D. |
Website | https://www.centurytx.com |
An error occurred while fetching data.
About Century Therapeutics, Inc.
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD